Longitudinal change in dopamine transporter availability in idiopathic REM sleep behavior disorder
- 8 December 2020
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Neurology
- Vol. 95 (23), e3081-e3092
- https://doi.org/10.1212/wnl.0000000000010942
Abstract
Objective To elucidate longitudinal changes in the dopamine transporter (DAT) availability in association with the prodromal markers in idiopathic REM sleep behavior disorder (iRBD), we analyzed a longitudinal prospective iRBD cohort data. Method The study cohort consisted of patients with iRBD, individuals with Parkinson disease (PD), and healthy controls. All participants were evaluated for olfaction, neuropsychological tests, and the Movement Disorders Society–Unified Parkinson's Disease Rating Scale and underwent 18F-FP-CIT PET scans every 2 years. We calculated the DAT pattern by performing the principal component analysis of tracer uptakes in 6 striatal regions. Result DAT patterns in patients with iRBD with baseline hyposmia, constipation, and mild parkinsonian signs distributed toward the PD pattern and clearly distinguished from the healthy control pattern. The DAT pattern moved toward the PD pattern over time in some patients with iRBD during the follow-up, and baseline hyposmia was the only biomarker significantly associated with this change. Baseline PD pattern of DAT predicted 58% of disease converters (hazard ratio 4.95 [95% confidence interval 1.16–21.08]). The combination of hyposmia and baseline PD pattern of DAT predicted 67% of the conversion (hazard ratio 7.89 [confidence interval 1.85–33.69]). The estimated sample size required for a simulated neuroprotective clinical trial was 63 per group when the annual change of DAT pattern was used as an outcome in the subgroup with baseline DAT PD pattern and hyposmia, which is the smallest number reported so far. Conclusion Baseline and longitudinal monitoring of the DAT pattern can be a useful biomarker in identifying individuals with a high risk of disease conversion and in selecting the potential population for clinical trials in iRBD.This publication has 33 references indexed in Scilit:
- Diagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement Disorder Society Task Force guidelinesMovement Disorders, 2012
- Cognition in Rapid Eye Movement Sleep Behavior DisorderFrontiers in Neurology, 2012
- Markers of neurodegeneration in idiopathic rapid eye movement sleep behaviour disorder and Parkinson's diseaseBrain, 2009
- Unified staging system for Lewy body disorders: correlation with nigrostriatal degeneration, cognitive impairment and motor dysfunctionActa Neuropathologica, 2009
- Mild cognitive impairment in rapid eye movement sleep behavior disorder and Parkinson's diseaseAnnals of Neurology, 2009
- Pathophysiology of REM sleep behaviour disorder and relevance to neurodegenerative diseaseBrain, 2007
- Striatal and extrastriatal dysfunction in Parkinson’s disease with dementia: a 6‐[18F]fluoro‐l‐dopa PET studyBrain, 2002
- Parametric mapping of [18F]FPCIT binding in early stage Parkinson's disease: A PET studySynapse, 2002
- Reduced striatal dopamine transporters in idiopathic rapid eye movement sleep behaviour disorderBrain, 2000
- Regional changes in [18F]dopa metabolism in the striatum in Parkinson's diseaseBrain, 1996